ATL-802

• UNSPSC Description:

  ATL-802 is a potent adenosine A2B receptor antagonist. ATL-802 is promising for research of diabetes[1].

• Target Antigen:

  Adenosine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/atl-802.html

• Smiles:

  O=C(C1=CC=C(C(F)(F)F)N=C1)N(C2=NC=C(C3=NC4=C(N(CCC)C(N(C5CC5)C4=O)=O)N3)C=C2)C

• Molecular Weight:

  513.47

• References & Citations:

  [1]LINDEN, Joel, et al. Reducing diabetes in patients receiving HMG-CoA reductase inhibitors (statins) comprising administering adenosine receptor antagonists or CD73 antagonists. WO2014153424 A1. 2014 September 25.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  847612-12-8